Literature DB >> 19473882

Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.

Kara L Cummings1, Hugo R Rosen, Young S Hahn.   

Abstract

CD4+ T cell responses are impaired in chronic HCV infection. To determine factor(s) involved in CD4+ T cell dysregulation, we examined the effect of extracellular core on the alteration of CD4+ T cell responses and the cell surface level of core-binding protein, gC1qR on CD4+ T cells from acute HCV patients with resolved and chronic infection. During the acute phase of infection, the frequency of gC1qR+CD4+ T cells increased in both resolved and chronic HCV infection compared to healthy controls. Notably, 6 months later, the frequency of gC1qR+CD4+ T cells maintained elevated in chronic patients compared to that in resolved patients. In addition, TCR stimulation increased the frequency of gC1qR+CD4+ T cells, resulting in core-induced inhibition of T cell responses in both resolved and chronic patients. These results suggest that HCV infection expands gC1qR+CD4+ T cells, which increase the susceptibility to core-mediated immune dysregulation and facilitate the establishment of HCV persistency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473882      PMCID: PMC2720442          DOI: 10.1016/j.clim.2009.05.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  34 in total

1.  Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase.

Authors:  A Widell; V Molnegren; F Pieksma; M Calmann; J Peterson; S R Lee
Journal:  Transfus Med       Date:  2002-04       Impact factor: 2.019

2.  Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.

Authors:  Hugo R Rosen; Camette Miner; Anna W Sasaki; David M Lewinsohn; Andrew J Conrad; Antony Bakke; H G Archie Bouwer; David J Hinrichs
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

3.  Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.

Authors:  G Icardi; F Ansaldi; B M Bruzzone; P Durando; S Lee; C de Luigi; P Crovari
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

4.  Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.

Authors:  P Maillard; K Krawczynski; J Nitkiewicz; C Bronnert; M Sidorkiewicz; P Gounon; J Dubuisson; G Faure; R Crainic; A Budkowska
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway.

Authors:  Z Q Yao; D T Nguyen; A I Hiotellis; Y S Hahn
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

6.  Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.

Authors:  D J Kittlesen; K A Chianese-Bullock; Z Q Yao; T J Braciale; Y S Hahn
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

7.  Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum.

Authors:  A Iijima; E Tanaka; M Kobayashi; S Yagi; M Mizokami; K Kiyosawa
Journal:  J Gastroenterol Hepatol       Date:  2000-03       Impact factor: 4.029

8.  Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help.

Authors:  Susan Smyk-Pearson; Ian A Tester; Jared Klarquist; Brent E Palmer; Jean-Michel Pawlotsky; Lucy Golden-Mason; Hugo R Rosen
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

9.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  Determinants of viral clearance and persistence during acute hepatitis C virus infection.

Authors:  R Thimme; D Oldach; K M Chang; C Steiger; S C Ray; F V Chisari
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

View more
  9 in total

Review 1.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

2.  Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.

Authors:  Naicui Zhai; Xiumei Chi; Tianyang Li; Hongxiao Song; Haijun Li; Xia Jin; Ian Nicholas Crispe; Lishan Su; Junqi Niu; Zhengkun Tu
Journal:  Cell Mol Immunol       Date:  2014-12-22       Impact factor: 11.530

3.  Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy.

Authors:  Lina Pednekar; Alisa Valentino; Yan Ji; Nithin Tumma; Christopher Valentino; Adarsh Kadoor; Kinga K Hosszu; Mahalakshmi Ramadass; Richard R Kew; Uday Kishore; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Mol Immunol       Date:  2016-04-23       Impact factor: 4.407

Review 4.  Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term Relationship.

Authors:  Ratna B Ray; Ranjit Ray
Journal:  Hepatology       Date:  2019-02       Impact factor: 17.425

5.  Hepatitis C virus proteins inhibit C3 complement production.

Authors:  Budhaditya Mazumdar; Hangeun Kim; Keith Meyer; Sandip K Bose; Adrian M Di Bisceglie; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

Review 6.  Complement and viral pathogenesis.

Authors:  Kristina A Stoermer; Thomas E Morrison
Journal:  Virology       Date:  2011-02-02       Impact factor: 3.616

Review 7.  Strategies to Circumvent Host Innate Immune Response by Hepatitis C Virus.

Authors:  Tapas Patra; Ratna B Ray; Ranjit Ray
Journal:  Cells       Date:  2019-03-22       Impact factor: 6.600

Review 8.  In the Crosshairs: RNA Viruses OR Complement?

Authors:  Nisha Asok Kumar; Umerali Kunnakkadan; Sabu Thomas; John Bernet Johnson
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

Review 9.  Let's Tie the Knot: Marriage of Complement and Adaptive Immunity in Pathogen Evasion, for Better or Worse.

Authors:  Kaila M Bennett; Suzan H M Rooijakkers; Ronald D Gorham
Journal:  Front Microbiol       Date:  2017-01-31       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.